TipRanks
Labcorp Holdings (CH:LH)
:LH
Switzerland Market
LH
Labcorp Holdings
RESEARCH TOOLSreports

Labcorp Holdings (LH) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

LH Analyst Ratings

Strong Buy
13Ratings
Strong Buy
10 Buy
3 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Labcorp
Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LH Stock 12 Month Forecast

Average Price Target

―
Based on 13 Wall Street analysts offering 12 month price targets for Labcorp Holdings in the last 3 months. The average price target is CHF284.51 with a high forecast of CHF314.74 and a low forecast of CHF253.45. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF314.74Average Price TargetCHF284.51Lowest Price TargetCHF253.45
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on CH:LH
Michael Cherny
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
09/23/26
Labcorp Holdings (LH) Receives a Buy from Leerink Partners
Truist Financial Analyst forecast on CH:LH
David S Macdonald
Truist Financial
Truist Financial
CHF289.9→CHF302.32
Buy
―
Reiterated
09/21/26
Labcorp price target raised to $365 from $350 at TruistLabcorp price target raised to $365 from $350 at Truist
Barclays Analyst forecast on CH:LH
Luke Sergott
Barclays
Barclays
CHF265.05→CHF273.33
Hold
―
Reiterated
09/11/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Labcorp Holdings (NYSE: LH) and Edwards Lifesciences (NYSE: EW)
William Blair Analyst forecast on CH:LH
Jared Haase
William Blair
William Blair
―
Buy
―
Reiterated
09/11/26
Jared Haase Reaffirms Buy on Labcorp, Citing Multi-Pillar Growth Strategy and Achievable Medium-Term Financial Targets
UBS Analyst forecast on CH:LH
Kevin Caliendo
UBS
UBS
CHF299.01→CHF314.74
Buy
―
Reiterated
09/11/26
Analysts Offer Insights on Healthcare Companies: Medicus Pharma Ltd (NASDAQ: MDCX) and Labcorp Holdings (NYSE: LH)
Evercore ISI Analyst forecast on CH:LH
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF281.61
Buy
―
Reiterated
09/11/26
Evercore ISI Remains a Buy on Labcorp Holdings (LH)
J.P. Morgan Analyst forecast on CH:LH
Lisa Gill
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
08/26/26
Regulatory Resilience and Strategic Upside Drive Lisa Gill’s Overweight/Buy Rating on Labcorp
Mizuho Securities Analyst forecast on CH:LH
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF265.05→CHF294.04
Buy
―
Reiterated
08/10/26
Labcorp price target raised to $355 from $320 at MizuhoLabcorp price target raised to $355 from $320 at Mizuho
Piper Sandler Analyst forecast on CH:LH
David Westenberg
Piper Sandler
Piper Sandler
CHF248.48→CHF255.94
Hold
―
Reiterated
08/04/26
Piper Sandler Remains a Hold on Labcorp Holdings (LH)
Morgan Stanley Analyst forecast on CH:LH
Erin Wright
Morgan Stanley
Morgan Stanley
CHF255.11→CHF279.96
Buy
―
Reiterated
07/31/26
Morgan Stanley Sticks to Their Buy Rating for Labcorp Holdings (LH)
Robert W. Baird Analyst forecast on CH:LH
Eric Coldwell
Robert W. Baird
Robert W. Baird
CHF279.96→CHF291.55
Buy
―
Reiterated
07/31/26
Labcorp price target raised to $352 from $338 at BairdLabcorp price target raised to $352 from $338 at Baird
Deutsche Bank Analyst forecast on CH:LH
Pito Chickering
Deutsche Bank
Deutsche Bank
CHF228.6→CHF253.45
Hold
―
Assigned
07/31/26
Labcorp price target raised to $306 from $276 at Deutsche BankLabcorp price target raised to $306 from $276 at Deutsche Bank
Bank of America Securities Analyst forecast on CH:LH
Michael Ryskin
Bank of America Securities
Bank of America Securities
CHF265.05→CHF298.18
Buy
―
Reiterated
07/30/26
Labcorp: Guidance Raised, Biopharma Momentum Strengthens, and Price Target Increased to $360 on Higher FY27 EBITDA Multiple
Argus Research Analyst forecast on CH:LH
David Toung
Argus Research
Argus Research
CHF256.77
Buy
―
Reiterated
06/02/26
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH), Moderna (NASDAQ: MRNA) and Celcuity (NASDAQ: CELC)
Citi Analyst forecast on CH:LH
Patrick B Donnelly
Citi
Citi
CHF269.19
Buy
―
Reiterated
01/02/26
Analysts' Top Healthcare Picks: Doximity (DOCS), Labcorp Holdings (LH)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on CH:LH
Michael Cherny
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
09/23/26
Labcorp Holdings (LH) Receives a Buy from Leerink Partners
Truist Financial Analyst forecast on CH:LH
David S Macdonald
Truist Financial
Truist Financial
CHF289.9→CHF302.32
Buy
―
Reiterated
09/21/26
Labcorp price target raised to $365 from $350 at TruistLabcorp price target raised to $365 from $350 at Truist
Barclays Analyst forecast on CH:LH
Luke Sergott
Barclays
Barclays
CHF265.05→CHF273.33
Hold
―
Reiterated
09/11/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Labcorp Holdings (NYSE: LH) and Edwards Lifesciences (NYSE: EW)
William Blair Analyst forecast on CH:LH
Jared Haase
William Blair
William Blair
―
Buy
―
Reiterated
09/11/26
Jared Haase Reaffirms Buy on Labcorp, Citing Multi-Pillar Growth Strategy and Achievable Medium-Term Financial Targets
UBS Analyst forecast on CH:LH
Kevin Caliendo
UBS
UBS
CHF299.01→CHF314.74
Buy
―
Reiterated
09/11/26
Analysts Offer Insights on Healthcare Companies: Medicus Pharma Ltd (NASDAQ: MDCX) and Labcorp Holdings (NYSE: LH)
Evercore ISI Analyst forecast on CH:LH
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF281.61
Buy
―
Reiterated
09/11/26
Evercore ISI Remains a Buy on Labcorp Holdings (LH)
J.P. Morgan Analyst forecast on CH:LH
Lisa Gill
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
08/26/26
Regulatory Resilience and Strategic Upside Drive Lisa Gill’s Overweight/Buy Rating on Labcorp
Mizuho Securities Analyst forecast on CH:LH
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF265.05→CHF294.04
Buy
―
Reiterated
08/10/26
Labcorp price target raised to $355 from $320 at MizuhoLabcorp price target raised to $355 from $320 at Mizuho
Piper Sandler Analyst forecast on CH:LH
David Westenberg
Piper Sandler
Piper Sandler
CHF248.48→CHF255.94
Hold
―
Reiterated
08/04/26
Piper Sandler Remains a Hold on Labcorp Holdings (LH)
Morgan Stanley Analyst forecast on CH:LH
Erin Wright
Morgan Stanley
Morgan Stanley
CHF255.11→CHF279.96
Buy
―
Reiterated
07/31/26
Morgan Stanley Sticks to Their Buy Rating for Labcorp Holdings (LH)
Robert W. Baird Analyst forecast on CH:LH
Eric Coldwell
Robert W. Baird
Robert W. Baird
CHF279.96→CHF291.55
Buy
―
Reiterated
07/31/26
Labcorp price target raised to $352 from $338 at BairdLabcorp price target raised to $352 from $338 at Baird
Deutsche Bank Analyst forecast on CH:LH
Pito Chickering
Deutsche Bank
Deutsche Bank
CHF228.6→CHF253.45
Hold
―
Assigned
07/31/26
Labcorp price target raised to $306 from $276 at Deutsche BankLabcorp price target raised to $306 from $276 at Deutsche Bank
Bank of America Securities Analyst forecast on CH:LH
Michael Ryskin
Bank of America Securities
Bank of America Securities
CHF265.05→CHF298.18
Buy
―
Reiterated
07/30/26
Labcorp: Guidance Raised, Biopharma Momentum Strengthens, and Price Target Increased to $360 on Higher FY27 EBITDA Multiple
Argus Research Analyst forecast on CH:LH
David Toung
Argus Research
Argus Research
CHF256.77
Buy
―
Reiterated
06/02/26
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH), Moderna (NASDAQ: MRNA) and Celcuity (NASDAQ: CELC)
Citi Analyst forecast on CH:LH
Patrick B Donnelly
Citi
Citi
CHF269.19
Buy
―
Reiterated
01/02/26
Analysts' Top Healthcare Picks: Doximity (DOCS), Labcorp Holdings (LH)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OMCLOmnicell
KNSAKiniksa Pharmaceuticals
ACHVAchieve Life Sciences
AHCOAdaptHealth
ZVRAZevra Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Labcorp Holdings

3 Months
Erin WrightMorgan Stanley
Success Rate
15/22 ratings generated profit
68%
Average Return
+4.72%
Copying Erin Wright's trades and holding each position for 3 Months would result in 68.18% of your transactions generating a profit, with an average return of +4.72% per trade.
1 Year
Erin WrightMorgan Stanley
Success Rate
19/22 ratings generated profit
86%
Average Return
+15.62%
Copying Erin Wright's trades and holding each position for 1 Year would result in 86.36% of your transactions generating a profit, with an average return of +15.62% per trade.
2 Years
Erin WrightMorgan Stanley
Success Rate
21/22 ratings generated profit
95%
Average Return
+28.19%
Copying Erin Wright's trades and holding each position for 2 Years would result in 95.45% of your transactions generating a profit, with an average return of +28.19% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LH Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
7
8
12
11
17
Hold
2
2
3
3
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
10
15
14
21
In the current month, LH has received 17 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. LH average Analyst price target in the past 3 months is 284.51.
Each month's total comprises the sum of three months' worth of ratings.

LH Financial Forecast

LH Earnings Forecast

Next quarter’s earnings estimate for LH is CHF3.89 with a range of CHF3.76 to CHF3.96. The previous quarter’s EPS was CHF4.17. LH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year LH has Performed in-line its overall industry.
Next quarter’s earnings estimate for LH is CHF3.89 with a range of CHF3.76 to CHF3.96. The previous quarter’s EPS was CHF4.17. LH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year LH has Performed in-line its overall industry.

LH Sales Forecast

Next quarter’s sales forecast for LH is CHF3.14B with a range of CHF3.13B to CHF3.16B. The previous quarter’s sales results were CHF3.12B. LH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year LH has Performed in-line its overall industry.
Next quarter’s sales forecast for LH is CHF3.14B with a range of CHF3.13B to CHF3.16B. The previous quarter’s sales results were CHF3.12B. LH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year LH has Performed in-line its overall industry.

LH Stock Forecast FAQ

What is CH:LH’s average 12-month price target, according to analysts?
Based on analyst ratings, Labcorp Holdings’s 12-month average price target is 284.51.
    What is CH:LH’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:LH, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Labcorp Holdings a Buy, Sell or Hold?
        Labcorp Holdings has a consensus rating of Strong Buy, which is based on 10 buy ratings, 3 hold ratings and 0 sell ratings.
          What is Labcorp Holdings’s share price target?
          The average share price target for Labcorp Holdings is 284.51. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF314.74 ,and the lowest forecast is CHF253.45. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Labcorp Holdings?
            Labcorp Holdings’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
              How can I buy shares of Labcorp Holdings?
              To buy shares of CH:LH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.